Myovant Sciences GmbH

🇨🇭Switzerland

Country: 🇨🇭Switzerland

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.myovant.com

Clinical Trials

LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Phase 3

Completed

Conditions: Heavy Menstrual Bleeding
Uterine Fibroid

Interventions: Drug: Relugolix
Drug: Estradiol/norethindrone acetate
Drug: Relugolix placebo
Drug: Estradiol/norethindrone acetate placebo

First Posted Date: 2017-02-10

Last Posted Date: 2022-04-19

Lead Sponsor: Myovant Sciences GmbH

Target Recruit Count: 388

Registration Number: NCT03049735

Locations: 🇺🇸
Clearwater, Clearwater, Florida, United States
🇺🇸
Hialeah, Hialeah, Florida, United States
🇺🇸
Chattanooga, Chattanooga, Tennessee, United States

and more 91 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy